Edgestream Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,187
| Closed | -$1.72M | – | 921 |
|
|
2024
Q1 | $1.72M | Buy |
+20,187
| New | +$1.72M | 0.09% | 368 |
|
|
2023
Q4 | – | Sell |
-2,945
| Closed | -$264K | – | 928 |
|
|
2023
Q3 | $264K | Buy |
+2,945
| New | +$264K | 0.02% | 741 |
|
|
2022
Q3 | – | Sell |
-31,440
| Closed | -$2.05M | – | 518 |
|
|
2022
Q2 | $2.05M | Buy |
31,440
+11,354
| +57% | +$740K | 0.16% | 199 |
|
|
2022
Q1 | $1.27M | Sell |
20,086
-2,211
| -10% | -$140K | 0.1% | 288 |
|
|
2021
Q4 | $1.18M | Buy |
+22,297
| New | +$1.18M | 0.07% | 291 |
|